Composition, form of production and packaging
Solution for infusions is transparent, colorless.
1 l
sodium chloride 8.6 g
calcium chloride 250 mg
potassium chloride 300 mg
[PRING] water d / and.
Theoretical osmolarity 309 mosm / L
200 ml - glass bottles (1) - packs of cardboard.
200 ml - glass bottles (15) - cardboard boxes.
200 ml - glass bottles (28) - cardboard boxes.
400 ml - glass bottles (1) - packs of cardboard.
400 ml - glass bottles (15) - cardboard boxes.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2011.
PHARMACHOLOGIC EFFECT
Rehydrating agent, has a detoxification effect, restores water and electrolyte blood composition. When used as a means of replenishing the volume of circulating blood, because of the rapid exit from the bloodstream into the extravasal space, the effect persists for only 30-40 minutes (in connection with which the solution is only suitable for short-term replenishment of the circulating blood volume).
INDICATIONS
Shock, thermal injury, acute blood loss; dehydration; intestinal fistula; acute intestinal infections (severe course, inability to take rehydrating drugs for oral administration); therapeutic plasmapheresis; correction of water and salt balance in acute diffuse peritonitis and intestinal obstruction.
DOSING MODE
In / in the drip, at a speed of 60-80 cap / min, or jet. The daily dose for adults - 5-20 ml / kg, if necessary, can be increased to 30-50 ml / kg. The daily dose for children is 5-10 ml / kg, the rate of administration is 30-60 cap / min, with shock initially administered 20-30 ml / kg. The course of treatment is 3-5 days. In therapeutic plasmapheresis is introduced in a volume that is 2 times greater than the volume of the removed plasma (1.2-2.4 L), in the case of pronounced hypovolemia - in combination with colloidal solutions. The maximum volume of the injected solution is 3 liters / day.
SIDE EFFECT
Hyperhydration, hypokalemia, allergic reactions.
CONTRAINDICATIONS
Hypersensitivity, hypernatremia, hyperchloremia, acidosis, severe chronic heart failure, cerebral edema, pulmonary edema, chronic renal failure, concomitant therapy with glucocorticosteroids.
PREGNANCY AND LACTATION
During pregnancy apply in cases where the expected benefit to the mother exceeds the possible risk to the fetus. It should refrain from breastfeeding during the period of use of the drug because of the lack of relevant clinical data.
APPLICATION FOR FUNCTIONS OF THE LIVER
Contraindicated in chronic renal failure.
SPECIAL INSTRUCTIONS
In the case of rapid introduction of a large volume, it is necessary to monitor the acid-base state and the concentration of electrolytes. A change in the pH of the blood leads to a redistribution of K + (a decrease in pH leads to an increase in the content of K + ions in the blood serum). Freezing the drug, provided that the tightness of the container is maintained, is not a contraindication to the use of the drug. If clouding, do not use the contents of the container. When combined with other drugs, you need to visually check for compatibility.
The ability to influence the reaction rate when driving or working with other machinery . Information is absent.
OVERDOSE
In case of an overdose, there may be a disturbance in the balance of water and electrolytes (hypervolemia, hypernatremia, hyperkalemia, hypercalcemia, hyperchloremia) and acid-base balance. In case of an overdose, in most cases, it's enough to interrupt the introduction.
TERMS OF RELEASE FROM PHARMACY
The drug is released by prescription.
TERMS AND CONDITIONS OF STORAGE
Keep out of the reach of children. Store at temperatures between 15 В° C and 25 В° C. Freezing the drug under the condition that the bottle is not leaking is not a contraindication to the use of the drug. Non-wetting of the inner surface of bottles is not a contraindication to the use of the drug.
Shelf life . 2 years. Do not use after the expiration date.
